28 days ago · China
How China plans to ‘firmly rank at the global forefront’ with 25% of first-in-class drugs
What's happening
SignalsMonitor is following this as a markets story. South China Morning Post Asia is the outlet attached so far. The reports are tied to China. The first report grouped here was at 18 Sept 2026, 08:00 UTC. The headline in use is “How China plans to ‘firmly rank at the global forefront’ with 25% of first-in-class drugs”. This note is SignalsMonitor's own briefing, not the publisher's article.
What we know
China has set its sights on becoming a global biomedicine powerhouse by 2030, targeting key technological breakthroughs and at least a quarter of the world’s first-in-class drugs market under a new five-year plan for the sector. By the end of the decade, China would “firmly rank at the global forefront”…
Story timeline
Reports grouped into this story, earliest first. Exact repeats from the same outlet are collapsed.
- First reported by South China Morning Post Asia
How China plans to ‘firmly rank at the global forefront’ with 25% of first-in-class drugs
Reported by 1 outlet
- South China Morning Post
- South China Morning PostHow China plans to ‘firmly rank at the global forefront’ with 25% of first-in-class drugs